Search Results - "Lleshi, A."

Transmission mode associated with coronavirus disease 2019: a review by Vella, F, Senia, P, Ceccarelli, M, Vitale, E, Maltezou, H, Taibi, R, Lleshi, A, Venanzi Rullo, E, Pellicanò, G F, Rapisarda, V, Nunnari, G, Ledda, C

“…In late December 2019 in Wuhan (China), Health Commission reported a cluster of pneumonia cases of unknown etiology, subsequently isolated and named Severe…”
Get more information

Effort myocardial ischemia during chemotherapy with 5-fluorouracil: an underestimated risk by Lestuzzi, C., Vaccher, E., Talamini, R., Lleshi, A., Meneguzzo, N., Viel, E., Scalone, S., Tartuferi, L., Buonadonna, A., Ejiofor, L., Schmoll, H.-J.

“…Effort-induced myocardial ischemia (EMI) has been seldom described. Aims of our study were (A) to evaluate the prevalence of EMI during long-lasting 5-FU…”
Get full text

Kaposi' s sarcoma in HIV-positive patients: the state of art in the HAART-era by La Ferla, L, Pinzone, M R, Nunnari, G, Martellotta, F, Lleshi, A, Tirelli, U, De Paoli, P, Berretta, M, Cacopardo, B

“…Kaposi's sarcoma (KS) is a multicentric angioproliferative cancer of endothelial origin typically occurring in the context of immunodeficiency, i.e…”
Get more information

Parent’s Experiences from the Treatment of their Children at the Physic Children’s Surgery Clinic in Skopje by Trajchevska, M., Lleshi, A., Gjoshev, S., Trajchevski, A.

“…Background: The respect of the needs and wishes of the patients is in the focus of the human health system. The experience of the parents in terms of child’s…”
Get full text

Long term cryopreservation in 5% DMSO maintains unchanged CD34+ cells viability and allows satisfactory hematological engraftment after peripheral blood stem cell transplantation by Abbruzzese, L., Agostini, F., Durante, C., Toffola, R. T., Rupolo, M., Rossi, F. M., Lleshi, A., Zanolin, S., Michieli, M., Mazzucato, M.

“…Peripheral blood stem cell cryopreservation is associated with cell damage and decreased viability. We evaluated the impact of up to 10 years of…”
Get full text

Lung cancer in HIV positive patients: the GICAT experience by Bearz, A, Vaccher, E, Martellotta, F, Spina, M, Talamini, R, Lleshi, A, Cacopardo, B, Nunnari, G, Berretta, M, Tirelli, U

“…AIDS incidence and mortality have decreased since the introduction of highly active antiretroviral therapy (HAART) into clinical practice. HIV-related…”
Get more information

THE ELDERLY PROGNOSTIC INDEX (EPI) PREDICTS EARLY MORTALITY IN OLDER PATIENTS WITH DLBCL. A SUBSTUDY OF THE ELDERLY PROJECT BY THE FONDAZIONE ITALIANA LINFOMI (FIL) by Merli, F., Tucci, A., Arcari, A., Rigacci, L., Cavallo, F., Cabras, G., Alvarez, I., Fabbri, A., Re, A., Ferrero, S., Puccini, B., Usai, S. V., Ferrari, A., Cencini, E., Pennese, E., Zilioli, V. R., Marino, D., Balzarotti, M., Cox, M. C., Zanni, M., Di Rocco, A., Lleshi, A., Botto, B., Hohaus, S., Merli, M., Sartori, R., Gini, G., Nassi, L., Musuraca, G., Tani, M., Bottelli, C., Kovalchuk, S., Re, F., Flenghi, L., Molinari, A., Tarantini, G., Chimienti, E., Marcheselli, L., Mammi, C., Luminari, S., Spina, M.

Get full text

Rational selection of predictive pharmacogenomics test for the Fluoropyrimidine/Oxaliplatin based therapy by Di Francia, R, De Lucia, L, Di Paolo, M, Di Martino, S, Del Pup, L, De Monaco, A, Lleshi, A, Berretta, M

“…Both Fluoropyrimidine and Oxaliplatin (FluOx) are the most common anticancer drugs used to treat colorectal, ovarian, and gastrointestinal cancers…”
Get more information

The Aquamantis® system as alternative for parenchimal divison and hemostasis in liver resection for hepatocellular carcinoma: a preliminary study by Spartà, D, Lleshi, A, Fisichella, R, Berretta, S

Get more information

Target Therapies in Lung Cancer by Bearz, A., Berretta, M., Lleshi, A., Tirelli, U.

“…Targeting intracellular signaling molecules is an attractive approach for treatment of malignancies. In particular lung cancer has reached a plateau regarding…”
Get full text

Treatment of 741 Italian patients with chronic fatigue syndrome by Tirelli, U, Lleshi, A, Berretta, M, Spina, M, Talamini, R, Giacalone, A

“…Chronic Fatigue Syndrome (CFS) is a distinctive syndrome characterized by specific symptoms cluster. CFS mostly affects women and often results in severe…”
Get more information

Feasibility of intraperitoneal Trastuzumab treatment in a patient with peritoneal carcinomatosis from gastric cancer by Berretta, M, Fisichella, R, Borsatti, E, Lleshi, A, Ioffredo, S, Meneguzzo, N, Canzonieri, V, Di Grazia, A, Cannizzaro, R, Tirelli, U, Berretta, S

“…This case report evaluates the feasibility and efficacy of intraperitoneal (IP) trastuzumab administration in gastric cancer (GC) patients with peritoneal…”
Get more information

Head and neck cancer survivors patients and late effects related to oncologic treatment: update of literature by Taibi, R, Lleshi, A, Barzan, L, Fiorica, F, Leghissa, M, Vaccher, E, De Paoli, P, Franchin, G, Berretta, M, Tirelli, U

“…Cancer survivorship represents a new challenge in the third Millennium. In Europe the number of cancer survivors was estimated to be 17,8 million in 2008 and…”
Get more information

Safety and efficacy of radiotherapy treatment in elderly patients with localized prostate cancer: A retrospective analysis by Fiorica, F, Berretta, M, Colosimo, C, Berretta, S, Ristagno, M, Palmucci, T, Palmucci, S, Lleshi, A, Ursino, S, Fisichella, R, Spartà, D, Stefanelli, A, Cappellani, A, Tirelli, U, Cartei, F

“…Abstract The purpose of this study was to evaluate the feasibility and the activity of radiotherapy treatment in patients aged ≥75 with prostate cancer (PC)…”
Get full text

Antiblastic treatment, for solid tumors, during pregnancy: a crucial decision by Berretta, M, Di Francia, R, Lleshi, A, De Paoli, P, Li Volti, G, Bearz, A, Del Pup, L, Tirelli, U, Michieli, M

“…Cancer is the second leading cause of death during the reproductive years complicating between 0.02 percent and 0.1 percent of pregnancies. The incidence is…”
Get more information

Oxaliplatin and capecitabine (Xelox) in association with highly active antiretroviral therapy in advanced hepatocarcinoma HIV/HCV-infected patients by Berretta, M., Lleshi, A., Di Benedetto, F., Bearz, A., Spina, M., Tirelli, U.

Get full text

Long Term Survival in a Patient with Adenocarcinoma of the Cystic Duct by Berretta, M., Di Benedetto, F., Lleshi, A., Ristagno, M., Cappellani, A., Bearz, A., Berretta, S., Tirelli, U.

Get full text

Antiblastic treatment of haematological malignancies during pregnancy: a crucial decision by Michieli, M, Peccatori, F A, Lleshi, A, Del Pup, L, Valente, D, Rupolo, M, Tirelli, U, Berretta, M

“…Antiblastic treatment of hematological malignancies during pregnancy poses a number of issues related to the curability of the maternal disease, the need of a…”
Get more information

FOLFOX2 in the Treatment of Advanced Colorectal Cancer: A Comparison Between Elderly and Middle Aged Patients by Berretta, M., Bearz, A., Frustaci, S., Talamini, R., Lombardi, D., Fratino, L., Lleshi, A., Bonanno, S., Spartà, D., Palmucci, S., Berretta, S., Tirelli, U.

“…The effectiveness of chemotherapy in elderly patients is still a matter of debate. We analyzed the toxicity and efficacy of the original FOLFOX2 regimen in…”
Get full text

Oxaliplatin-based chemotherapy in association with highly active antiretroviral therapy in metastatic colorectal cancer HIV-infected patients by Berretta, M., Simonelli, C., Lleshi, A., Lacchin, T., Bearz, A., di Gennaro, G., Vaccher, E., Tirelli, U.

Get full text